Stay updated on Roll Over Study 1199.30 BIBF 1120 Clinical Trial
Sign up to get notified when there's something new on the Roll Over Study 1199.30 BIBF 1120 Clinical Trial page.

Latest updates to the Roll Over Study 1199.30 BIBF 1120 Clinical Trial page
- Check5 days agoChange DetectedAn NIH-wide notice about updated terminology appears above the unchanged 403 error page. The site revision label also changes from v3.7.1 to v3.7.2.SummaryDifference1%

- Check12 days agoNo Change Detected
- Check19 days agoChange DetectedThe footer’s displayed site revision changes from v3.7.0 to v3.7.1; the page continues to show a 403 error.SummaryDifference0.2%

- Check33 days agoChange DetectedThe page now shows a 403 Forbidden error, replacing the study record content and navigation. Access to the study details is no longer available on this page.SummaryDifference17%

- Check40 days agoChange DetectedThe page shows a new revision identifier, updating from v3.6.6 to v3.7.0. This reflects a system or UI version upgrade rather than a change to study content or data.SummaryDifference0.0%

- Check54 days agoChange DetectedThe page now displays Revision: v3.6.6 instead of v3.6.5, indicating a recent deployment. The change represents a site update and does not modify trial details or eligibility information.SummaryDifference0.0%

- Check61 days agoChange DetectedThe page gained new informational sections such as NIH grant/contract details, Related Info, sponsor attribution to Boehringer Ingelheim, and Helpful Links, along with drug/device information. These additions offer broader context and easier access to related materials without altering the study details.SummaryDifference0.2%

Stay in the know with updates to Roll Over Study 1199.30 BIBF 1120 Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Roll Over Study 1199.30 BIBF 1120 Clinical Trial page.